Full text is available at the source.
Abstract
Patients with inflammatory bowel disease (IBD) on immunomodulatory therapy may have diminished responses to SARS-CoV-2 vaccination.
- Humoral responses to the vaccine could be lower in patients with IBD receiving immunomodulatory therapy.
- Cellular responses to vaccination may also be affected in this patient population.
- The study monitored vaccine responses over a period of 12 months.
Simplified